Predisposition to essential hypertension and renal hemodynamics in recent-onset insulin-dependent diabetic patients.
The offspring of essential hypertensive parents have been found to exhibit abnormalities in renal hemodynamics and sodium handling before the eventual occurrence of hypertension. The reported abnormalities represent a wide spectrum of changes including increased GFR, normal or decreased RPF, slight increase in blood pressure (although within the normal range), and an exaggerated natriuresis response to a sodium load. The heterogeneity of these abnormalities may reflect the specific conditions of the studies, the lability of the changes, or different subgroups of subjects with genetic predisposition to essential hypertension. Several lines of evidence have suggested a relationship between hypertension and the development of diabetic nephropathy in insulin-dependent diabetics. This laboratory has found that recent-onset insulin-dependent diabetics can exhibit renal hemodynamics abnormalities very early in the course of diabetes according to a positive or negative family history of essential hypertension. These changes include increased GFR and mean arterial pressure, but no differences in renal sodium and lithium handling in diabetics with a genetic predisposition to essential hypertension. In addition, diabetics with a positive family history of essential hypertension exhibited a more-marked vasodilative response to an acute interruption of the renin-angiotensin system, further suggesting inadequate angiotensin modulation of renal vascular tone. The significance of these abnormalities in relation to the development of diabetic nephropathy requires further investigation.
Hannedouche
T P
TP
Department of Nephrology, Hôpital Necker, Paris, France.
Marques
L P
LP
Guicheney
P
P
Lacour
B
B
Boitard
C
C
Grünfeld
J P
JP
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000209:etiology / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D008094:Lithium / Q000378:metabolism; D012079:Renal Circulation; D012964:Sodium / Q000378:metabolism
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D008094:Lithium; D012964:Sodium